Pin1 as a central node in oncogenic signaling: Mechanistic insights and clinical prospects (Review)

Shuning Lei1, Min Luo1, Yuxue Wang1

  • 1Department of Laboratory Medicine, Hubei University of Chinese Medicine, Wuhan, Hubei 430065, P.R. China.

PubMed

Insights

Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (Pin1) regulates cell cycle, proliferation, and apoptosis. Pin1

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (Pin1) is a key regulator of cellular processes.
  • Pin1's role in cell cycle, proliferation, and apoptosis is critical in both normal physiology and pathology.
  • Aberrant Pin1 activity is implicated in various cancers.

Purpose of the Study:

  • To elucidate the mechanistic role of Pin1 in tumorigenesis.
  • To review recent advancements in understanding Pin1's function in cancer development.
  • To explore Pin1 as a potential diagnostic biomarker and therapeutic target in oncology.

Main Methods:

  • Literature review of studies on Pin1 function in cancer.
  • Analysis of Pin1's involvement in cell cycle regulation, signaling pathways, and tumor suppressor functions.
  • Examination of the correlation between Pin1 expression and cancer prognosis.

Main Results:

  • Pin1 promotes cancer cell proliferation and metastasis by modulating the cell cycle and signaling pathways.
  • Upregulated Pin1 expression is linked to poor prognosis across multiple cancer types.
  • Pin1 influences the function of critical tumor suppressors.

Conclusions:

  • Pin1 is a significant factor in tumor initiation and progression.
  • Pin1 represents a promising biomarker for cancer diagnosis and prognosis.
  • Pin1 emerges as a potential therapeutic target for anticancer strategies.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...